QA: Paratek Pharmaceuticals Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2019_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 255,243,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 1,173,000
3 remainder_Assets 42,947,000
4 LiabilitiesCurrent 17,709,000
5 LiabilitiesNoncurrent 234,905,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 94,919,036
9 ResearchAndDevelopmentExpense 56,927,706
10 remainder_Expenses 17,195,688
11 remainder_Revenues 16,796,665
12 remainder_NetIncome 2,782,516
13 remainder_ComprehensiveNetIncome -141,542
  yvar yval
0 Assets 300,192,000
1 Liabilities 252,614,000
2 Expenses 169,042,430
3 Revenues 16,796,665
4 StockholdersEquity 47,578,000
5 NetIncome -149,463,249
6 ComprehensiveNetIncome -149,534,020
7 BaseVar 370,784,576
8 EconomicCapitalRatiobeforeLimitedLiability -0.166
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time